2024
Jun 01, 2024

Positive clinical trial results (SARC032, SARC037) highlighted at ASCO

2023
Sep 14, 2023

Inaugural SASS conference, co-hosted with NCI

May 10, 2023

The SARC Multidisciplinary Tumor Board (SMTB) launched

SMTB provides innovative multidisciplinary discussion for adults and children with sarcoma at any stage of the disease.

ABOUT THE TUMOR BOARD

SARC History
Mar 01, 2023

Celebrated 20th anniversary, $80 million invested in sarcoma research

2022
Feb 18, 2022

Chief medical officer position established

EORTC Logo (grey background)
Jan 01, 2022

EORTC (pan-European group)

Analysis of multiple SARC trials to understand chemotherapy response in more common sarcomas.

ABOUT EORTC

2021
Nov 11, 2021

SARC041

Phase III Abemaciclib vs. Placebo in Advanced Dedifferentiated Liposarcoma

ABOUT THIS TRIAL

Jun 04, 2021

SARC038

Phase II study of Regorafenib and Nivolumab in Osteosarcoma

ABOUT THIS TRIAL

Animated Patient
May 24, 2021

Launched Animated Patient Educational Series

Understanding Adoptive Cell Therapy for Sarcoma

WATCH VIDEO

Jan 05, 2021

SARC037

Phase I Trabectedin plus Irinotecan and (18F-FLT) Imaging in Ewings Sarcoma
A Phase I study to evaluate the safety of Trabectedin administered as a one hour infusion in Ewing Sarcoma patients in combination with low dose Irinotecan and 3′-Deoxy-3′-18F Fluorothymidine (18F-FLT) imaging.

ABOUT THIS TRIAL

Jan 01, 2021

ESTABLISHED Chief Scientific Officer position

Jonathan Fletcher, MD

LEARN MORE

2020
Oct 01, 2020

appointed new president & ceo

Steven Young

READ BIO

SARC Research Advocacy Logo (grey background)
Jan 01, 2020

Formed SARC Research Advocacy Council

2018
Sarcoma Coalition (grey background)
Jan 01, 2018

Helped Establish Sarcoma Coalition

Sarcoma patient advocacy foundations working together.

SARCOMA COALITION

2015
Mar 01, 2015

SARC028

Phase II Pembrolizumab (MK-3475) for Advanced Sarcomas
First study to test immune checkpoint inhibitors in advanced sarcoma.

ABOUT THIS TRIAL

2014
Jul 01, 2014

SARC024

Oral Regorafenib in Selected Sarcoma Subtypes
First active systemic therapy in metastatic Osteosarcoma in 30 years.

ABOUT THIS TRIAL

Jan 22, 2014

SARC021

Phase III TH-302 with Doxorubicin vs. Doxorubicin Alone in Soft Tissue Sarcoma
First phase III trial in over 100 centers.

ABOUT THIS TRIAL

2012
NIH Logo (grey background)
Oct 11, 2012

SARC Sarcoma SPORE

Awarded five-year Sarcoma Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute. The first such award in any cancer type that connected multiple cancer centers to work collaboratively.

ABOUT SARCOMA SPORE

2009
Jan 01, 2009

Launched Career Development Program

Research grants awarded to early-stage, young physicians/scientists dedicated to defeating sarcoma.

ABOUT THE CAREER DEVELOPMENT PROGRAM

2007
Dec 18, 2007

SARC011

Phase II R1507 in Recurrent or Refractory Sarcoma
First international clinical trial.

ABOUT THIS TRIAL

2003
SARC Logo (grey background)
Oct 13, 2003

Sarcoma Alliance for Research through Collaboration (SARC)

Founded by sarcoma researchers.
Jan 27, 2003

SARC001

Phase II Imatinib Mesylate in Soft Tissue and Bone Sarcomas
First SARC clinical trial.

ABOUT THIS TRIAL

Back to top